2020 BD launched the first sample preparation and flow cytometry system to enable clinical laboratories to fully automate the sample-to-answer process. 2021 BD launched the first ready-to-use aqueous povidone-iodine (PVP-I) surgical irrigation solution. Bard might be a scam, please verify by searching for the posting on the careers page or contact us at Please be aware of potentially fraudulent job postings on other websites or suspicious recruiting email or text messages that attempt to collect your confidential information. Email AddressWe’ll send job alerts and updates here Create a job alert to be notified when positions that match your skills and location become available.
1987 BD built a plant to manufacture diagnostic products in Fukushima, Japan. 1999 The world’s shortest, thinnest insulin pen needle is introduced. 2007 BD AutoShield™ needle is launched. 2015 BD became the first to integrate IV pumps with electronic health records.
2017 The first clinical lab application of artificial intelligence and robotics to automatically report and release negative urine cultures is utilized. 2019 BD launched the first venous stent to treat iliofemoral venous occlusive disease. 2014 BD launched the first FDA-approved drug coated balloon for peripheral artery disease. 2015 BD became the first to integrate IV pumps with electronic health records.\r\n 2017 The first clinical lab application of artificial intelligence and robotics to automatically report and release negative urine cultures is utilized.\r\n 2019 BD launched the first venous stent to treat iliofemoral venous occlusive disease.\r\n
“Doc” Fleischer, developer of the mercurial sphygmomanometer, merged his company with BD. 1940 BD launched the first sterilization technology for devices. 1947 BD hired Joseph Kleiner, who brings his multi-fit syringe and his idea for the evacuated tube.
1948 BD founders turn over the company to their sons. 1956 BD enters the Brazilian syringe market and quickly becomes the largest provider in the country with two modern plants and HQ in Sao Paulo. 1955 BD begins using AMI of France to manufacture steel tubes for hypodermic needles. 1981 A new plant is built in Plymouth, England to manufacture BD Vacutainer® system khelaghor-bangladesh.com/bd/ products and serve a growing European market.
Sign up to get the latest company news, events, and future opportunities straight to your inbox. At BD, your ideas, curiosity and purpose can makea global impact In December 2025, BD was sued by Tela Bio Inc., makers of a ovine forestomach matrix hernia mesh, who alleged that BD engaged in anticompetitive practices to push Tela out of the market for surgical meshes while raising prices for providers and patients. Food and Drug Administration and worldwide health agencies to coordinate recall activities. The approximately 2.8 million BD Q-Syte and 2.9 million BD Nexiva units containing 5 million BD Q-Syte devices that were recalled were distributed in the United States, Asia, Canada, Europe, Mexico, the Middle East, South Africa, and South America.
This agreement protects patents and intellectual properties of both companies ensuring the quality and integrity of Embecta Corporation’s cannulas used in their products. The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard. In October 2014, the company agreed to acquire CareFusion for a price of US$12.2 billion in cash and stock. Later Retractable would claim BD was falsely advertising its own brand of retractable needle as the “world’s sharpest needle”. Retractable would accuse BD of patent infringement after BD released a retractable needle of its own. The company was founded in 1897 in New York City by Maxwell Becton and Fairleigh S. Dickinson.
